← Scroll for more →
Financial Statements — BDMD
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|
| Cash & Equivalents | 0.18 | 2.17 | 2.97 |
| Accounts Receivable | 42.53 | 40.82 | 46.58 |
| Inventory | 1.09 | 1.43 | 1.30 |
| Total Current Assets | 54.97 | 60.75 | 61.42 |
| Property, Plant & Equipment | 6.37 | 6.71 | 7.14 |
| Goodwill | 0.06 | 0.06 | 0.06 |
| Intangible Assets | 0.01 | 0.01 | 0.02 |
| Total Non-current Assets | 14.73 | 16.24 | 16.55 |
| Total Assets | 69.70 | 76.99 | 77.96 |
| Accounts Payable | 1.81 | 2.14 | 1.25 |
| Total Current Liabilities | 32.36 | 35.47 | 34.62 |
| Long-term Debt | 8.72 | 8.41 | 4.45 |
| Total Non-current Liabilities | 6.11 | 5.90 | 3.58 |
| Total Liabilities | 38.48 | 41.37 | 38.20 |
| Retained Earnings | (0.52) | 15.45 | 26.76 |
| Total Stockholder Equity | 31.37 | 35.59 | 39.66 |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 |
|---|---|
| Total Revenue | 7.96 |
| Cost of Revenue | 1.42 |
| Gross Profit | 6.54 |
| Research & Development | 7.18 |
| Selling, General & Admin | 8.68 |
| Total Operating Expenses | 16.99 |
| Operating Income | (10.45) |
| Pretax Income | (10.80) |
| Tax Provision | 0.56 |
| Net Income | (11.36) |
| Basic EPS | (0.43) |
| Diluted EPS | (0.43) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2025 |
|---|---|
| Operating Cash Flow | (3.19) |
| Capital Expenditures | 0.04 |
| Free Cash Flow* | (3.24) |
| Investing Cash Flow | (0.04) |
| Financing Cash Flow | 2.20 |
← Scroll for more columns →
* Derived from reported values